As insulin use itself was associated with risk of severe hypoglycemia (aHR, 3.07; 95% CI, 3.00-3.14) (eTable 1 in the Supplement), NAFLD appears to have less additive association. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.